T. Rowe Price Associates’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$590K Buy
48,201
+755
+2% +$9.24K ﹤0.01% 2227
2025
Q1
$680K Buy
47,446
+2,538
+6% +$36.4K ﹤0.01% 2134
2024
Q4
$715K Sell
44,908
-20,317
-31% -$323K ﹤0.01% 2114
2024
Q3
$1.57M Buy
65,225
+589
+0.9% +$14.2K ﹤0.01% 1752
2024
Q2
$1.29M Buy
64,636
+3,738
+6% +$74.5K ﹤0.01% 1776
2024
Q1
$1.21M Sell
60,898
-192
-0.3% -$3.82K ﹤0.01% 1822
2023
Q4
$1.37M Buy
61,090
+2,581
+4% +$57.9K ﹤0.01% 1715
2023
Q3
$1.18M Sell
58,509
-21,558
-27% -$436K ﹤0.01% 1714
2023
Q2
$2.05M Sell
80,067
-35,133
-30% -$898K ﹤0.01% 1465
2023
Q1
$3.43M Sell
115,200
-11,201
-9% -$333K ﹤0.01% 1280
2022
Q4
$3.42M Sell
126,401
-656
-0.5% -$17.7K ﹤0.01% 1267
2022
Q3
$2.77M Sell
127,057
-9,657
-7% -$210K ﹤0.01% 1331
2022
Q2
$3.74M Buy
136,714
+174
+0.1% +$4.76K ﹤0.01% 1458
2022
Q1
$4.57M Buy
136,540
+2,560
+2% +$85.8K ﹤0.01% 1474
2021
Q4
$4.65M Sell
133,980
-2,027,116
-94% -$70.3M ﹤0.01% 1505
2021
Q3
$67.4M Sell
2,161,096
-314,180
-13% -$9.8M 0.01% 906
2021
Q2
$90M Sell
2,475,276
-745,607
-23% -$27.1M 0.01% 816
2021
Q1
$141M Sell
3,220,883
-273,699
-8% -$12M 0.01% 662
2020
Q4
$160M Sell
3,494,582
-59,345
-2% -$2.72M 0.02% 582
2020
Q3
$118M Sell
3,553,927
-498,164
-12% -$16.5M 0.01% 605
2020
Q2
$119M Sell
4,052,091
-274,671
-6% -$8.07M 0.02% 586
2020
Q1
$117M Sell
4,326,762
-335,327
-7% -$9.03M 0.02% 530
2019
Q4
$157M Buy
4,662,089
+106,187
+2% +$3.58M 0.02% 535
2019
Q3
$171M Sell
4,555,902
-370,070
-8% -$13.9M 0.02% 488
2019
Q2
$215M Sell
4,925,972
-23,466
-0.5% -$1.02M 0.03% 450
2019
Q1
$211M Sell
4,949,438
-57,828
-1% -$2.47M 0.03% 452
2018
Q4
$224M Buy
5,007,266
+101,538
+2% +$4.55M 0.04% 407
2018
Q3
$336M Buy
4,905,728
+41,191
+0.8% +$2.82M 0.05% 364
2018
Q2
$278M Sell
4,864,537
-30,311
-0.6% -$1.74M 0.04% 389
2018
Q1
$226M Sell
4,894,848
-347,511
-7% -$16M 0.04% 433
2017
Q4
$242M Sell
5,242,359
-20,418
-0.4% -$943K 0.04% 417
2017
Q3
$237M Sell
5,262,777
-137,111
-3% -$6.17M 0.04% 412
2017
Q2
$212M Sell
5,399,888
-227,535
-4% -$8.94M 0.04% 422
2017
Q1
$214M Sell
5,627,423
-86,549
-2% -$3.3M 0.04% 415
2016
Q4
$211M Sell
5,713,972
-109,196
-2% -$4.04M 0.04% 415
2016
Q3
$202M Sell
5,823,168
-91,840
-2% -$3.18M 0.04% 420
2016
Q2
$192M Buy
5,915,008
+213,040
+4% +$6.93M 0.04% 418
2016
Q1
$164M Buy
5,701,968
+23,025
+0.4% +$662K 0.04% 437
2015
Q4
$190M Buy
5,678,943
+1,266,553
+29% +$42.3M 0.04% 415
2015
Q3
$125M Buy
4,412,390
+110,630
+3% +$3.15M 0.03% 518
2015
Q2
$174M Buy
4,301,760
+962,790
+29% +$39M 0.04% 477
2015
Q1
$164M Buy
3,338,970
+149,035
+5% +$7.33M 0.03% 480
2014
Q4
$145M Buy
+3,189,935
New +$145M 0.03% 509